Ken Keller News Today

Nearly three dozen pre-nursing students will soon gain hands-on experience alongside healthcare professionals in a hospital setting through an internship provided by Taft College.

AstraZeneca plc and Daiichi Sankyo's Enhertu has gained US approval for treating HER2-positive solid tumours, marking a significant advancement in cancer treatment.

On Friday, the FDA approved Daiichi Sankyo Ltd’s (OTC:DSKYF) (OTC:DSNKY) and AstraZeneca Plc’s (NASDAQ:AZN) Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. This indication is approved under accelerated approval based on objective response rate (ORR) and duration of response (DOR). Continued approval fo...

Press Release ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Apr 5, 2024--

Based on three Phase II trials of AstraZeneca and Daiichi Sankyos Enhertu which showed clinically meaningful responses across a broad range of tumours ...

This is the fifth indication for fam-trastuzumab deruxtecan-nxki (Enhertu; Daiichi Sankyo and AstraZeneca) approved by the FDA.

Nearly 300 hospitals across the country were rated "high performing" in a new list of the Best Hospitals for Maternity Care compiled by U.S. News & World Report.

The Greater Bakersfield Chamber announced Friday it has selected the head of a local nonprofit to lead one of Kerns central business organizations at a critical time of transition for

Taft College is coming up with new ways to help Kern County employers find their future workforce while also giving students the chance to see how well a career in